- Home
- PTEN vs VRDN Comparison
PTEN vs VRDN Comparison
Compare PTEN & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTEN
- VRDN
- Stock Information
- Founded
- PTEN 1978
- VRDN 2006
- Country
- PTEN United States
- VRDN United States
- Employees
- PTEN N/A
- VRDN 143
- Industry
- PTEN Oil & Gas Production
- VRDN Medical Specialities
- Sector
- PTEN Energy
- VRDN Health Care
- Exchange
- PTEN Nasdaq
- VRDN Nasdaq
- Market Cap
- PTEN 2.5B
- VRDN 2.7B
- IPO Year
- PTEN 1993
- VRDN N/A
- Fundamental
- Price
- PTEN $5.97
- VRDN $28.72
- Analyst Decision
- PTEN Buy
- VRDN Strong Buy
- Analyst Count
- PTEN 10
- VRDN 11
- Target Price
- PTEN $7.35
- VRDN $39.60
- AVG Volume (30 Days)
- PTEN 10.2M
- VRDN 2.0M
- Earning Date
- PTEN 10-22-2025
- VRDN 11-05-2025
- Dividend Yield
- PTEN 5.35%
- VRDN N/A
- EPS Growth
- PTEN N/A
- VRDN N/A
- EPS
- PTEN N/A
- VRDN N/A
- Revenue
- PTEN $4,837,946,000.00
- VRDN $70,789,000.00
- Revenue This Year
- PTEN N/A
- VRDN N/A
- Revenue Next Year
- PTEN N/A
- VRDN $37,670.06
- P/E Ratio
- PTEN N/A
- VRDN N/A
- Revenue Growth
- PTEN N/A
- VRDN 23340.07
- 52 Week Low
- PTEN $5.10
- VRDN $9.90
- 52 Week High
- PTEN $9.58
- VRDN $29.27
- Technical
- Relative Strength Index (RSI)
- PTEN 48.58
- VRDN 74.31
- Support Level
- PTEN $5.88
- VRDN $22.14
- Resistance Level
- PTEN $6.56
- VRDN $28.60
- Average True Range (ATR)
- PTEN 0.28
- VRDN 1.29
- MACD
- PTEN -0.06
- VRDN 0.41
- Stochastic Oscillator
- PTEN 28.31
- VRDN 93.20
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).